Suppr超能文献

萘普生微乳体系的设计与表征

Design and characterization of microemulsion systems for naproxen.

作者信息

Moghimipour Eskandar, Salimi Anayatollah, Eftekhari Soroosh

机构信息

Nanotechnology Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Adv Pharm Bull. 2013;3(1):63-71. doi: 10.5681/apb.2013.011. Epub 2013 Feb 7.

Abstract

PURPOSE

This research was aimed to formulate and characterize a microemolsion systems as a topical delivery system of naproxen for relief of symptoms of rheumatoid arthritis, osteoarthritis and treatment of dysmenorrheal.

METHODS

ME formulations prepared by mixing of appropriate amount of surfactant including Tween 80 and Span 80, co-surfactant such as propylene glycol (PG) and oil phase including Labrafac PG - transcutol P (10:1 ratio). The prepared microemolsions were evaluated regarding their particle size, zeta potential, conductivity, stability, viscosity, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), refractory index (RI) and pH.

RESULTS

The mean droplets size of microemulsion formulation were in the range of 7.03 to 79.8 nm, and its refractory index (RI) and pH were 1.45 and 6.75, respectively. Viscosity range was 253.73- 802.63cps. Drug release profile showed that 26.15% of the drug released in the first 24 hours of experiment. Also, Hexagonal and bicontinuous structures were seen in the SEM photograph of the microemulsions.

CONCLUSION

characterization, physicochemical properties and in vitro release were dependent upon the contents of S/C ratio, water and, oil phase percentage in formulations. Also, ME-6 may be preferable for topical naproxen formulation.

摘要

目的

本研究旨在制备并表征一种微乳剂系统,作为萘普生的局部给药系统,用于缓解类风湿性关节炎、骨关节炎症状及治疗痛经。

方法

通过混合适量的表面活性剂(包括吐温80和司盘80)、助表面活性剂(如丙二醇(PG))和油相(包括Labrafac PG - 二甲基亚砜(比例为10:1))来制备微乳剂。对制备的微乳剂进行粒度、zeta电位、电导率、稳定性、粘度、差示扫描量热法(DSC)、扫描电子显微镜(SEM)、折光率(RI)和pH值等方面的评估。

结果

微乳剂配方的平均液滴尺寸在7.03至79.8纳米范围内,其折光率(RI)和pH值分别为1.45和6.75。粘度范围为253.73 - 802.63厘泊。药物释放曲线表明,在实验的前24小时内,26.15%的药物被释放。此外,在微乳剂的SEM照片中观察到六方和双连续结构。

结论

表征、理化性质和体外释放取决于配方中表面活性剂/助表面活性剂比例、水和油相百分比的含量。此外,ME - 6可能是萘普生局部制剂的优选配方。

相似文献

1
Design and characterization of microemulsion systems for naproxen.萘普生微乳体系的设计与表征
Adv Pharm Bull. 2013;3(1):63-71. doi: 10.5681/apb.2013.011. Epub 2013 Feb 7.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验